Search Results 691-700 of 16285 for pharmacogenetics
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...
This study evaluates the safety and tolerability of extended dosing with ISIS-TTR Rx in patients with Familial Amyloid Polyneuropathy. Participation eligibility.
Mayo Clinic has achieved a significant milestone with its Tapestry study, generating the clinic's largest-ever collection of exome data — key to ...
The purpose of this study is to evaluate the sasfety and effectiveness of MK-7264 in reducing cough frequency as measured over a 24-hour period. Participation ...
Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “G” to learn about drug side effects, proper use and ...
The purpose of this study is to determine if microbiome DNA can be detected in the juice from the upper GI tract and that of the clinical residual specimens ...
Knowledge is power. That's Rose Boettcher's philosophy. Genetic counseling helped this three-time cancer survivor make decisions about her health care. Her test ...
To address this, Dr. Acosta and a team of Mayo Clinic researchers set out to study anti-obesity medications based on obesity phenotypes to enhance weight loss.
Niloy Jewel Samadder, M.D.. “While the overall incidence of disease progression was not lower, the combination therapy of the drugs sulindac and eflornithine ...
The purpose of this study is to define a comprehensive digital phenotype through radio signal-enabled passive environment monitoring, associated with clinical ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.